NCT06107634 (PEH3) is a NA clinical trial of Gastropexy in Paraesophageal Hernia, sponsored by Ersta Diakoni.

Who is sponsoring NCT06107634?

NCT06107634 is sponsored by Ersta Diakoni.

What drugs are being tested in NCT06107634?

Interventions in NCT06107634: Gastropexy, Paraesophageal hernia repair.

What condition does NCT06107634 study?

NCT06107634 studies Paraesophageal Hernia.

Is NCT06107634 still recruiting?

NCT06107634 is currently recruiting now. Last updated 18 December 2024.

Last reviewed 2024-12-18 · How we verify

NCT06107634: PEH3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gastropexy in the Repair of Patients with Paraesophageal Hernias

Recruiting now NA Last updated 18 December 2024

What this trial tests

NA trial testing Gastropexy in Paraesophageal Hernia in 124 participants. Currently enrolling.

Timeline

1 June 2023

Primary endpoint
2 August 2027

2 August 2030

Quick facts

Lead sponsor	Ersta Diakoni
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	124
Start date	1 June 2023
Primary completion	2 August 2027
Estimated completion	2 August 2030
Sites	6 locations across Sweden

Drugs / interventions tested

Gastropexy
Paraesophageal hernia repair

Conditions studied

Paraesophageal Hernia — all drugs for Paraesophageal Hernia →

Sponsor

Ersta Diakoni

Who can join

18 and older, any sex, with Paraesophageal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional surgical hernia repair or with the addition of gastropexy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Can gastropexy reduce the recurrence rate after paraesophageal hernia repair? A study protocol for a double blind, randomized, multicenter clinical trial.
Dackhammar JB, Tsoposidis A, Wallenius V, Kostic S, et al · · 2026 · PMID 41840686 · DOI 10.1186/s13063-026-09578-7

Verify or expand the search:

Other recruiting trials for Paraesophageal Hernia

Currently open trials in the same condition.

NCT06725433 — Nissen Versus Dor Hiatal Hernia Repair · NA · recruiting
NCT05201508 — Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair · NA · recruiting
NCT04179578 — The Value of Lateral Release in Reconstruction of the Diaphragmatic Hiatus Hernia · NA · active not recruiting

Other Ersta Diakoni trials

Trials by the same sponsor.

NCT06071559 — Bariatric Surgery on obesity-and Diabetes-associated Abnormalities of Hemostasis, Inflammation and Vascular Function. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06107634 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ersta Diakoni
Last refreshed: 18 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06107634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing